Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell ; 82(15): 2885-2899.e8, 2022 08 04.
Article in English | MEDLINE | ID: mdl-35841888

ABSTRACT

Translated small open reading frames (smORFs) can have important regulatory roles and encode microproteins, yet their genome-wide identification has been challenging. We determined the ribosome locations across six primary human cell types and five tissues and detected 7,767 smORFs with translational profiles matching those of known proteins. The human genome was found to contain highly cell-type- and tissue-specific smORFs and a subset that encodes highly conserved amino acid sequences. Changes in the translational efficiency of upstream-encoded smORFs (uORFs) and the corresponding main ORFs predominantly occur in the same direction. Integration with 456 mass-spectrometry datasets confirms the presence of 603 small peptides at the protein level in humans and provides insights into the subcellular localization of these small proteins. This study provides a comprehensive atlas of high-confidence translated smORFs derived from primary human cells and tissues in order to provide a more complete understanding of the translated human genome.


Subject(s)
Gene Expression Regulation , Ribosomes , Genome, Human/genetics , Humans , Open Reading Frames/genetics , Protein Biosynthesis , Proteins/metabolism , RNA/metabolism , Ribosomes/genetics , Ribosomes/metabolism
2.
Rheumatology (Oxford) ; 60(12): 5820-5826, 2021 12 01.
Article in English | MEDLINE | ID: mdl-33590875

ABSTRACT

OBJECTIVES: Interleukin 11 (IL11) is highly upregulated in skin and lung fibroblasts from patients with systemic sclerosis (SSc). Here we tested whether IL11 is mechanistically linked with activation of human dermal fibroblasts (HDFs) from patients with SSc or controls. METHODS: We measured serum IL11 levels in volunteers and patients with early diffuse SSc and manipulated IL11 signalling in HDFs using gain- and loss-of-function approaches that we combined with molecular and cellular phenotyping. RESULTS: In patients with SSc, serum IL11 levels are elevated as compared with healthy controls. All transforming growth factor beta (TGFß) isoforms induced IL11 secretion from HDFs, which highly express IL11 receptor α-subunit and the glycoprotein 130 (gp130) co-receptor, suggestive of an autocrine loop of IL11 activity in HDFs. IL11 stimulated ERK activation in HDFs and resulted in HDF-to-myofibroblast transformation and extracellular matrix secretion. The pro-fibrotic action of IL11 in HDFs appeared unrelated to STAT3 activity, independent of TGFß upregulation and was not associated with phosphorylation of SMAD2/3. Inhibition of IL11 signalling using either a neutralizing antibody against IL11 or siRNA against IL11RA reduced TGFß-induced HDF proliferation, matrix production and cell migration, which was phenocopied by pharmacological inhibition of ERK. CONCLUSIONS: These data reveal that autocrine IL11-dependent ERK activity alone or downstream of TGFß stimulation promotes fibrosis phenotypes in dermal fibroblasts and suggest IL11 as a potential therapeutic target in SSc.


Subject(s)
Gene Expression Regulation , Interleukin-11 Receptor alpha Subunit/genetics , Interleukin-11/blood , MAP Kinase Signaling System/genetics , RNA/genetics , Scleroderma, Systemic/blood , Skin/pathology , Biomarkers/blood , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Humans , Interleukin-11 Receptor alpha Subunit/biosynthesis , Scleroderma, Systemic/genetics , Scleroderma, Systemic/pathology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...